N. Inoue

A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer

E. Hatano, T. Chiba, M. Asada, 2011, Cancer Chemotherapy and Pharmacology.

Conversion to Complete Resection with mFOLFOX6 with Bevacizumab or Cetuximab Based on K-RAS Status for Unresectable Colorectal Liver Metastasis (BECK study): Long-Term Results of Survival.

E. Hatano, S. Uemoto, Kojiro Nakamura, 2020, Journal of hepato-biliary-pancreatic sciences.

[Molecular target therapy for gastroenteropancreatic neuroendocrine tumors].

M. Imamura, M. Awane, I. Komoto, 2012, Nihon rinsho. Japanese journal of clinical medicine.

[A case of AFP-producing gastric cancer resected after efficient S-1/CDDP combination chemotherapy].

Takefumi Nakamura, N. Inoue, S. Uose, 2011, Gan to kagaku ryoho. Cancer & chemotherapy.

Outcomes of Neoadjuvant Chemotherapy without Radiation for Rectal Cancer

Y. Sakai, S. Hasegawa, Takuya Matsumoto, 2015, Digestive Surgery.

Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K‐ras status for unresectable colorectal liver metastasis (BECK study)

E. Hatano, S. Uemoto, Kojiro Nakamura, 2015, Journal of hepato-biliary-pancreatic sciences.

gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer

E. Hatano, T. Chiba, M. Asada, 2017 .